ARCT logo

Arcturus Therapeutics Holdings Inc. Common Stock

ARCT

ARCT: Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the segment of research and development of medical applications for nucleic acid-focused technology. The product pipeline of the company includes LUNAR-OTC, LUNAR-CF, and LUNAR-COV19.

more

Show ARCT Financials

Chart and Financial Data provided by TradingView

All
Government
Consumer Interest
SEC Filings
ESG/Other
Congress Trading

Recent trades of ARCT by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by ARCT's directors and management

Corporate Lobbying

Government lobbying spending instances

  • $20,000 Jul 17, 2021 Issue: Health Issues Medicare/Medicaid
  • $20,000 Apr 19, 2021 Issue: Health Issues Medicare/Medicaid
  • $90,000 Jan 19, 2021 Issue: Budget/Appropriations Medicare/Medicaid Health Issues
  • $100,000 Oct 25, 2020 Issue: Medical/Disease Research/Clinical Labs
  • $80,000 Oct 19, 2020 Issue: Budget/Appropriations Medicare/Medicaid Health Issues
  • $30,000 Apr 17, 2020 Issue: Medical/Disease Research/Clinical Labs
U.S. Patents

New patents grants

  • Patent Title: Molecules and agents for treating hepatitis b virus Jun. 27, 2023
  • Patent Title: Compositions and methods for treating ornithine transcarbamylase deficiency Jun. 27, 2023
  • Patent Title: Ionizable cationic lipid for rna delivery Oct. 04, 2022
  • Patent Title: Synthetic transfer rna with extended anticodon loop Sep. 06, 2022
  • Patent Title: Translatable molecules and synthesis thereof Aug. 09, 2022
  • Patent Title: Synthesis and structure of high potency rna therapeutics May. 25, 2021
  • Patent Title: Ionizable cationic lipid for rna delivery Apr. 20, 2021
  • Patent Title: Compositions and agents against hepatitis b virus and uses thereof Mar. 30, 2021
  • Patent Title: Ionizable cationic lipid for rna delivery Mar. 30, 2021
  • Patent Title: Messenger una molecules and uses thereof Oct. 27, 2020
  • Patent Title: Method of synthesis of an ionizable cationic lipid Sep. 22, 2020
  • Patent Title: Acyl-amino-lna and/or hydrocarbyl-amino-lna oligonucleotides Aug. 04, 2020
  • Patent Title: Una oligomers having reduced off-target effects in gene silencing Jun. 16, 2020
  • Patent Title: Ionizable cationic lipid for rna delivery Feb. 11, 2020
  • Patent Title: Ionizable cationic lipid for rna delivery Jan. 07, 2020
  • Patent Title: Therapeutic una oligomers and uses thereof Dec. 31, 2019
  • Patent Title: Trinucleotide mrna cap analogs Nov. 26, 2019
  • Patent Title: Una oligomers for therapeutics with prolonged stability Oct. 29, 2019
  • Patent Title: Una oligomers and compositions for treating amyloidosis Sep. 24, 2019
  • Patent Title: Ionizable cationic lipid for rna delivery Sep. 03, 2019
  • Patent Title: Ionizable cationic lipid for rna delivery Aug. 20, 2019
  • Patent Title: Allele selective gene editing and uses thereof Aug. 06, 2019
  • Patent Title: Aromatic ionizable cationic lipid Mar. 19, 2019
  • Patent Title: Ionizable cationic lipid for rna delivery Mar. 12, 2019
  • Patent Title: Transthyretin allele selective una oligomers for gene silencing May. 29, 2018
  • Patent Title: Multiligand agent for drug delivery May. 08, 2018
  • Patent Title: Ionizable cationic lipid for rna delivery Apr. 24, 2018
  • Patent Title: Una single stranded oligomers for therapeutics Apr. 17, 2018
  • Patent Title: Ionizable cationic lipid for rna delivery Feb. 20, 2018
  • Patent Title: Formulations for treating amyloidosis Jan. 02, 2018
  • Patent Title: Ionizable cationic lipid for rna delivery Dec. 26, 2017
  • Patent Title: Aromatic ionizable cationic lipid Dec. 05, 2017
  • Patent Title: Ionizable cationic lipid for rna delivery Jun. 06, 2017
  • Patent Title: Ionizable cationic lipid for rna delivery Mar. 14, 2017
  • Patent Title: Lipid particles with asymmetric cationic lipids for rna delivery Feb. 28, 2017
  • Patent Title: Ionizable cationic lipid for rna delivery Feb. 14, 2017
  • Patent Title: Asymmetric ionizable cationic lipid for rna delivery Jun. 14, 2016
  • Patent Title: Una oligomer structures for therapeutic agents May. 17, 2016
  • Patent Title: Una duplex oligomers for therapeutics Apr. 05, 2016
  • Patent Title: Una oligomers targeting micro-rna for therapeutics Mar. 29, 2016
  • Patent Title: Una oligomers for therapeutics Jun. 09, 2015
Government Contracts

Federal grants, loans, and purchases

WallStreetBets

Number of mentions of ARCT in WallStreetBets Daily Discussion

ARCT News

Recent insights relating to ARCT

CNBC Recommendations

Recent picks made for ARCT stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in ARCT

Corporate Flights

Flights by private jets registered to ARCT